Matthew Holdren – Biography
Last update: June 9, 2026Executive profile
Matthew was Vice President and Head of Nonclinical Development at Lycia Therapeutics, and Vice President of Nonclinical Development at Tenaya Therapeutics.
Matthew Holdren is currentlyVice President of Toxicology at Septerna - View - Septerna org chart
Create your alert
to follow the career of Matthew Holdren.
Education
Matthew Holdren has a PhD in pathology from University of Washington.
They have also studied at University of Washington :
Find more alumni from University of Washington
More about Matthew Holdren
Selected links
Do you need to know more about Matthew Holdren? More results.
Participate
Social media
- Matthew Holdren on Google News, X (Twitter), LinkedIn, YouTube
- View the pictures of Matthew Holdren
The colleagues of Matthew Holdren
Company Colleagues
- At Septerna, Matthew Holdren has 24 colleagues including Jeffrey Finer (CEO), Abraham Bassan (Director)…
Industry Colleagues
- In the Biotechnology industry, Matthew Holdren has 35,919 colleagues in 2,426 companies located in 45 countries. 17,064 executive movements have been recorded in the last 12 months. Learn more about Biotechnology.
Report an error
Update the org chart details of Matthew Holdren.
Get in Touch
Here are a few tips for establishing great contacts.
